Dermala

About:

DERMALA develops personalized, clinically validated, patented treatments for chronic skin conditions including acne & eczema.

Website: https://www.dermala.com/

Twitter/X: dermalainc

Top Investors: Seventure Partners, True Wealth Ventures, Johnson & Johnson Robotics and Digital Solutions, Cove Fund

Description:

DERMALA is a consumer dermatology company leveraging scientific understanding of the human microbiome and data analytics to develop personalized, clinically validated, patented treatments for chronic skin conditions including acne and eczema. The company’s #FOBO® (Fear of Breaking Out) system, a personalized microbiome-based solution for acne, combines patented topical acne treatments and oral supplements with a proprietary DERMALA Acne Tracker app that customers use to track their skin health and get their treatment optimized monthly. For more information, visit dermala.com.

Total Funding Amount:

$7.65M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2014-01-01

Contact Email:

fobo(AT)dermala.com

Founders:

Lada Rasochova

Number of Employees:

1-10

Last Funding Date:

2020-11-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai